Erweiterte Suche

Derzeit hat Srinivas Tallapragada die Position des Co-President & Chief Engineering Officer bei salesforce.com, inc. In seiner früheren Karriere war Herr Tallapragada Senior Vice President bei Oracle Corp. Srinivas Tallapragada hat einen Hochschulabschluss von der Xavier School of Management und einen Bachelor-Abschluss vom National Institute of Technology, Warangal.

Srinivas G.
Rao was the founder of Kyalin Biosciences, Inc. (founded in 2011) where he served as the Chief Executive Officer from 2011 to 2013.
He is also the founder of ATAI Life Sciences AG (founded in 2018) where he currently holds the position of Chief Scientific Officer.
Additionally, he is the founder of Kures, Inc. (founded in 2019) and ATAI Life Sciences NV (founded in 2018), both of which he currently serves as the Chief Scientific Officer.
Dr. Rao is also the founder of IntroSpect Digital Therapeutics, Inc. Dr. Rao's current job(s) include being the Chief Executive Officer at EntheogeniX Biosciences, Inc. since 2019, a Director at Perception Neuroscience, Inc., a Member of the Society For Neuroscience, and a Member of the American College of Neuropsychopharmacology.
Dr. Rao's former job(s) include being the Chief Scientific Officer & Director-Science at Cypress Bioscience, Inc. from 2000 to 2009, a Non-Executive Director at Bionomics Ltd.
from 2020 to 2021, a Director at IntelGenx Technologies Corp.
from 2021 to 2023, the Chief Medical Officer & Senior Vice President at Assertio Therapeutics, Inc. from 2014 to 2017, the Executive VP & Head-Neuroscience Division at Travere Therapeutics, Inc. from 2013 to 2014, and the Chief Medical Officer at Axial Therapeutics, Inc. from 2017 to 2019.
Dr. Rao's education includes a doctorate from Yale School of Medicine and a doctorate from Yale Graduate School of Arts & Sciences.